Dow Down 0.56% Nasdaq Down 0.79%

Coherus Biosciences, Inc. (CHRS)

-NasdaqGM
18.65 Down 0.46(2.41%) 4:00PM EDT
Prev Close:19.11
Open:19.00
Bid:11.12 x 100
Ask:N/A
1y Target Est:37.75
Beta:1.71
Next Earnings Date: 9-May-16CHRS Earnings announcement
Day's Range:18.58 - 19.17
52wk Range:12.04 - 38.10
Volume:209,407
Avg Vol (3m):228,285
Market Cap:729.95M
P/E (ttm):N/A
EPS (ttm):-6.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CHRS

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):24.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.84
Quarterly EPS Est (Mar-16) :-1.42
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. The company’s product candidates include CHS-1701, a pegfilgrastim biosimilar candidate, whi... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback